Translating Evidence to Clinical Practice to Improve Outcomes in Patients with Small Cell Lung Cancer

In a recent OncLive® Scientific Interchange moderated by David R. Gandara, MD, experts discussed the prevalence and pathobiology of SCLC cases in their practices; the role of surgery, radiation, prophylactic cranial irradiation (PCI), and systemic therapy in LS-SCLC; and optimal systemic approaches for ES-SCLC in the first-line and relapsed settings.

EP: 1.Dr. Melosky on the Use of Lurbinectedin in SCLC

EP: 2.Dr. Bazhenova on the Challenges of Second-Line Therapy in SCLC

EP: 3.Dr. Florez (Duma) on Nihilism in SCLC

Now Viewing

EP: 4.Translating Evidence to Clinical Practice to Improve Outcomes in Patients with Small Cell Lung Cancer

Related Videos